Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Should read "all the technical's is meaningless.
Wild Bill
I have enjoyed your posts,but what I am responded to is:
A dead cat is a dead cat and you can't resurrect a dead cat.
I took a large loss with CPST and left it months ago.
Unless CPST gets positive results and repeats it for two or more quarters then the cat IS DEAD.
All the technical is or is not is meaningless.
And I say,'AMEN' I have no quarrel with your observations and opinions. That's history. BTW CPST was my largest loss for my portfolio this year,because I saw it earlier.unfortunately too late.
CC 11/06/2015. Here is the 'lipstick' on the pig. Quote from D.J.
Average revenue for the Company over the last 18 quarters was approximately $30 million, with revenue exceeding that level nine times and reaching at least $27 million, 13 out of the last 18 quarters. Based upon the new cost structure, which will reduce expenses by 25%, the Company would have been break even or very close 13 of the last 18 quarters.
I did not listen to the CC,but the energy efficiency market was strong this quarter and comprised 68% of our sales, and natural resources applications accounted for 26% of sales," Mr. Jamison continued.
"We still have challenges ahead from the continued economic headwinds, the strong U.S. dollar and the drop in oil and commodity prices. However, with a new lower cost structure, improved CHP product offerings and increased sales efforts in emerging markets, we believe we will be able to overcome these challenges and improve our financial results throughout the upcoming year. Further, as a result of our initiatives, we expect to be better positioned for sustainable growth when oil prices rebound and the dollar weakens, " Mr. Jamison concluded.
This last glimmer of HOPE rest on D.J comment in the CC.
CPST is now on my watch list and we shall see.
Bankruptcy, not with standing.
I always believed in the product.
Sometimes that is not going to make the shareholders any profits.
Management????
HOPE. Should not be a sentiment in your investing lexicon.
Facts,numbers,observation,deduction even intuitive gut instinct are what must be applied when trading or investing.
GLTY
NVAX is enrolling for RSV Ph 3. I called and verified with the organization enrolling. As far as I know NVAX did not announce it yet. Could be a catalyst.NVAX is now on an uptrend.
Should be "fair" shake. Sorry.
When the Bruce Willis character in "Pulp Fiction" said to his babe "Zed is Dead" I think of CPST. I have been a long term shareholder in CPST and sold out awhile ago. I have no involvement anymore. I guess I just want to say. Good Luck to you all.Simply because I am still a believer in the technology,but gave up on the probability of success in this company. Sorry. I am still watching for a MIRACLE.
I hope you all get a fare shake.
Sorry shareholders,but that whole Russian thing got me out at .54 months ago.
Now CPST is cutting expenses by trimming merit bonuses,cutting overtime,etc.
A reverse split is all that is left and with no institutional interest apparently only die hard retail investors are left holding the bag.
The headwinds are just too great for this company to survive regardless of the product.
Penny stock and I mean penny stock prices or bankruptcy seems inevitable.Today or tomorrow will see retail leaving for the exits.
Best to you guys,I enjoyed the ride at the time I was invested.
Biotech is on a fire sale.
I am averaging in on severe declines like today and trade out on pops. Holding a core for fundamentals. I listened in on today"s investor"s conference here in NY and am seriously impressed with their entire pipeline,especially the RSV vaccine.
I have been trading NVAX for years and it is my main source of trading profits.
FWIW. I could almost gaurantee the stock would pop pre market. It did. I was out at 9.35 on yesterday"s buy at 8.40. Then typically as NVAX does it tanks up to 10 am then usually rebounds which today was brief. I am now picking up stock in increments below 8 and just now 6.54. This my friends is a fire sale for the biotech crush will reverse I think sooner then later.
The ETF"s selling are driving down all biotechs. Astute traders will be in with a rush sometime hopefully soon. We shall see. GTLA
You can not hold a short position forever.
The borrowed shares can be called back at any time,you may have to pay hard to borrow rates which are variable and your potential loss is unlimited.
ITEK has a float of 16 million shares-- that is VERY LOW.
A short squeeze with limited liquidity is a recipe for disaster.
Be careful my friend. I would only short this stock for only a few days,not more becUse the inherent risk fAr out ways the over valuation.
Thanks. Please keep your ear to the wall.
Thanks for the good thoughts.
I'll still be around,simply because of the time I've been a shareholder.
The question I ask myself is why be a shareholder.
There are other horizons,opportunities,tables and places to be.
I believed in the product and it is a fabulous product, question is: is the company's management or the product ahead of itself.
I just bought Fitbit for a day trade. Made a one day trade of 6%.
Today it's up another 8 %.
So I ask you why do you keep your investment in a company that over the years can't even come close to producing that result.
Like I said before.
Know when to fold and look somewhere else.
Tired of management .
Rather look somewhere else.
Classic over promise,under deliver.
I am out except for a minor position.
Sold out earlier this year,my biggest loss this year (realized).
Thanks to my short term and day trading I am still positive this year,but not even close to last year.
The choice of what one invests in is similar to a poker hand,pulling to a inside straight is not a good idea.
And that's why I threw in my hand here.
Took my money off the table,changed tables, and am still in the game,but without that bad feeling of why the hell did I call that hNd.
You got to know when to fold'm.
GLTA you will need it.
Good for you.
I have not,but then again I'm the type that takes the money rather than curtain 1 in Let's Make a Deal.
When I first started buying equities I over extended myself on a limited number of positions and had my share of bankrupt companies. Took me many years to recoup. Painful lessons.
But I'm still in the game 40 years later wiser for the experience.
I am retired and enjoy short term trading.
It's my substitute for playing poker.
And I never play the lottery.
For me like playing poker- it probability of outcome and risk vs reward.
If you want to stay in this game then diversification is key.
ISR being a MICROCAP without significant sales but a promising product only warrants a small position to be held for the long hall.
On the other hand I'll risk 50000 to make 1000 only if the situation warrants that trade and is usually a day trade.
GLTU
And one more thing. A micro cap will not be more than 3 to 5 percent of my portfolio. And they must muster some degree of possibility. For any of you newbies, of which, I am sure are involved on this board, be mindful. There is no such thing as "hitting the lottery" or to "the moon Alice". And when the fundamentals do not bear fruition DO NOT BE A SUCKER to your nativity.
Be diversified, be aware, be focused, and work on the execution.
Enough said.
I concur.
Do not forget the fundamentals and the time needed to get this company on track. Most of all go back a week and look at what happened, especially the share volume, the price movement and the DUMB MONEY.
Sorry I am 2 hours after responding, been trading other stocks, but it still stands this is a manipulated stock. DO NOT get carried away, much fundamentals still needs to be done by company. Sales,sales,sales. Rest is B.S.
I believe that this is decent proposition for long term involvement. Keeping in mind IT IS A MICROCAP with all that in-tales.
Must be patient here- this stock is sucking in DUMB MONEY for a BIG HIT.
Good Luck there.
Thanks for the technicals.
I tend to keep it simple using a technique I picked up a few years back. Using just four indicators that when lined up give a decent percentage probability to direction. After years of use I have relied on this with nice results.
Don't ask what they are- not for release,but if you look the info. Is out there.
Be careful a lot of manipulation. I added on a few hundred at 2 and a few hundred at 1.84 pre market.
A break below 1.78 till I add more,unless there is a good reason based on news from company.
Remember they still have to sell product and I am going to conference next Friday to see them in person. If I can get in. It is a professional presentation.
Nothing changed fundamentally. Market trading by pros on small cap stock with limited float causing great volatility.
Remember the recent term base is around 1.57. I added this am at 1.84 and am looking to add more below 1.70.
This is a long term hold measured in months to years.
If you want to trade go to more known stocks with liquidity. Less of a problem with entry and exit. Also more stable and measurable.
Give it time and wait for a catalyst to occur.
I have a small order in at 1.84.
Sorry,but the opposite is true. Generally a forward split lowers the stock price so it becomes more attractively priced for the masses. When a stock price is in trouble like not qualifying for a listing on an exchange that's when a reverse split takes place. Reverse splits are the kiss of death not because it split (that has no bearing on the market cap), but because the perception the company price is such that it needs to be boosted to remain on a listed exchange.
Here is one person's view on ISR Take it as you will.
http://cnafinance.com/isoray-stock-will-the-climb-continue/3043
What you do is not buy after a 85 percent run up. Remember stocks are trading vehicles and there are plenty of investors and traders who are happy to sell you their 2 dollar stock at 2.5 or 3 or 3.5.
WAIT and see what happens. Then buy -even if you must some stock at 3.7 but a fraction of what you plan to buy then average in. You want stock at a discount. Example. I plan to add ISR into my portfolio. I want it to be 5% of my total. My portfolio is 100,000.
5% equals 5000. Stock is at 3.7 I can't wait (even though you should because it already ran up 85%). So you buy 10% at 3.7.
Then you see the stock come in you buy 20% at the close say 2.20.
Then you wait another day or more because you have no idea where the stock will settle. When it establishes a base or news comes out and the stock rebounds you add another 30% or not depending.Let's say the company refutes a negative news story and the stock rebounds on the open you buy the 30% as I stated. You have 40 % to go. Best to wait for a few days or weeks to add the remaining 40%.And that you can do in pieces. By buying in increments you avoid that sick feeling of a large loss that frequently happens when you DO NOT THINK and plan rationally. So you bought 5000 at 3.7 that's 18,500. And at 2 you are down 8500 and are ready to sell at 3 for a 2 or 4 day loss at 3500 with the sinking feeling of how stupid you feel. Based on what- being undisciplined and emotional.\
Stop and think before you hit the buy and sell buttons.
Then you would not have to write "Don't know what I am going to do.. Disturbed badly."
If you want to make money in any market --STOP,THINK AND PLAN.
I hope this helps. And I am only writing this because I have been there many years ago.
If anything, it is a win for cancer patients and good info. to know.
From th most recent earning call:
IsoRay Chairman and CEO Dwight Babcock commented, "Clinical evidence provided through protocols/studies performed by major medical centers is proving utilizing Cesium-131 is either equal to or better than the current standard of care alternatives. This evidence, coupled with patients enjoying an improved quality of life, remains the key to IsoRay's success. Studies also aid in generating awareness and ultimately general adoption by community hospitals and physicians, which will in turn drive consumers to our product offerings. To this end and given this growing acceptance and interest in our now published results, IsoRay remains committed to our strategic sales and marketing objectives, which we believe will contribute to long term growth and achieving profitability."
The rest is execution and that takes time,not a day ,a week or a month.
Old adage, "buy on weakness and sell into strenght.
I don"t have a clue and does it matter?
I will spend tonight doing some fundamental research on the companies financials,their respect in the medical community,their business plans to market,etc.
At least ISR is not a biotech in a phase trial.
Whoever wants to short this company is fine with me. It is only more demand down the line.
When I go shopping I NEVER pay retail and if the downside pressure knocks the price lower GREAT time to pick some up.
ISR is not far from last October range to May 20 0f approx. 1.20's to 2.
Now if what I first believe to be true (and I took the trouble to go to their website and listen to some of the research doctor's reports)then we all might be advised to due some real research,be patient and start giving this company some respect.
I am not their yet but did start buying this P.M. on weakness.
More work to do.
Fun isn't it.
BTW I like to trade some stocks,indices or breaking news items,but when I do it's very short term.
I agree. Did you read the entire post.
Security law firms are like roaches. They all come out on the first hint of something to feast on.
FWIW,
Someone is short because they borrowed the shares,they do not own the shares Today's volume is nothing more then active short term trading. I could purchase and sell 10000 shares 100 times today showing 1 million shares in the volume report. From Yahoo finance:
Share Statistics
Avg Vol (3 month)3: 1,575,430
Avg Vol (10 day)3: 6,789,300
Shares Outstanding5: 54.88M
Float: 54.47M
% Held by Insiders1: 1.25%
% Held by Institutions1: 4.00%
Shares Short (as of Apr 15, 2015)3: 4.11M
Short Ratio (as of Apr 15, 2015)3: 6.90
Short % of Float (as of Apr 15, 2015)3: 7.50%
Shares Short (prior month)3: 3.65M
And as of 4:48 pm today you have your 2 dollar number
AH 1.90
You have until 8 pm to buy if you like.
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against IsoRay, Inc. - ISRFont size: A | A | A
3:38 PM ET 5/21/15 | BusinessWire
The Rosen Law Firm, P.A., a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of IsoRay, Inc. (NYSE:ISR) resulting from allegations that IsoRay may have issued materially misleading business information to the investing public.
On May 21, 2015, TheStreet.com published an article stating that the Company's promotional press releases regarding the publication of a study concerning its Celsium-131 product are misleading. On this news, shares of IsoRay fell during mid-day trading $0.90 per share or 29% from its previous closing price of $3.12 per share on May 20, 2015, damaging investors.
The Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by IsoRay investors. If you purchased shares of IsoRay on or before May 21, 2015, please visit the website at http://rosenlegal.com/cases-623.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
READ BELOW ABOUT THE STREET.COM AND alan feuernstein
Washington, D.C. — Citizens for Responsibility and Ethics in Washington (CREW) today requested the Securities and Exchange Commission (SEC) investigate possible illegal manipulation of stock prices in Northwest Biotherapeutics, a biotechnology company developing cancer treatment drugs. Strategically released blog posts by well-known biotech stock analyst and senior columnist for TheStreet.com Adam Feuerstein seem designed to cause the price of the company’s stock to fall at times when short sellers were financially overexposed. CREW has asked the SEC and the U.S. Attorney for the Southern District of New York to conduct a full investigation of the timing of Mr. Feuerstein’s posts and their relationship to short seller financial interests.
Read CREW's letter to the SEC and supporting exhibits.
“When several drug companies repeatedly see big stock price dips due to a negative articles published at critical moments — especially when those dips benefit the financial interests of short sellers — it should raise serious questions at the SEC. Given the suspicious timing of Mr. Feuerstein’s articles, which include misinformation and innuendo, there should be an inquiry into whether there was a deliberate effort to manipulate the market for profit,” CREW Executive Director Melanie Sloan said.
CREW’s request for an investigation highlights several examples where Mr. Feuerstein’s blog posts and Twitter communications appear intended to send the stock prices plummeting of three pharmaceutical companies — Northest Biotherapeutics, GTx, and Mannkind — at a time when short shares were at a peak.
On June 18, 2014, Northwest Biotherapeutics’ stock was trading at $8.97, a near record high for the stock. Prior reporting from SmithonStocks.com noted the “intense shorting program” aimed at the company’s stock and that the rising stock prices set the stage for a “major short squeeze.” The following morning, before trading began, Mr. Feuerstein posted a series of tweets hinting the company had received bad news related to testing of its promising cancer drug. He then posted a blog item criticizing the company for releasing interim testing data, and quoting a doctor not involved with the study who suggested the company’s release of data was both highly unusual and inappropriate. As a result, by the close of trading on June 19, the stock lost 20 percent of its value and has continued to slide.
CREW’s letter to the SEC also notes similar suspicious timing related to Mr. Feuerstein’s reporting on drug companies GTx and Mannkind. As GTx’s stock reached near-record levels in July 2013, Mr. Feuerstein published an article predicting the failure of a critical drug trial, citing an unnamed short seller as a source. Mr. Feuerstein refused to correct the multiple errors in his article despite a point-by-point refutation by a GTx investor posted on seekingalpha.com. Similarly, in March 2014, Mr. Feuerstein published an article predicting a 60-percent chance the Food and Drug Administration (FDA) would reject the company’s new drug, Afrezza. By the end of the day, Mannkind’s shares were trading at a 10-month low. Contrary to Mr. Feurstein’s prognostication, on April 1, an FDA advisory committee granted marketing approval for Afreeza by a vote of 13 to 1.
“Where there is smoke, there’s often fire. Maybe it’s just a coincidence that Mr. Feuerstein’s unduly negative articles appear at critical moments for these companies, but it certainly merits an investigation,” Ms. Sloan said.
Ignore AF. He is a known biotech basher. He has his reasons and they are for you to sell your shares.
BTW the volume is nothing more then day traders going in and out.
The news is good and my dd says that this is a long term accumulate.
My price is between 1.6 and 2.2 with an average around 2.
You will need patience of a couple of years for a core holding.
Trade all you want otherwise.
Watch the volume dry up in the coming weeks back to normal.
This is a news generated rally and a normal sell off from the opening 2 dollars to today's high above 3.5 pre market.
I just came across this company today and started buying my allotment this p.m.
Let's control our enthusiam and be sensible.
There should be no "going to the moon ALICE" POSTS.
glta
Sorry to say but I must go.
Need to preserve my Capital
Been in CPST long time.
LONG T I M E
Getting too old for what may be,
Did that done that.
Am talking my loses and
I HOPOE FOR YOU LONG TIMERS I AM WRONG
This is one of my most worrysome investments.
CPST is simply not executing as well as they should and the macro events are not helping.
Holding higher with lowest price at .79.
All I can do here is cross my fingers on both hands and pray the good fairy waves her wand on the shareholders.
Now that is fabulous investment advice. Yes?
goaler2933
Good for you. You may be intuitive,lucky or shrewd.
No matter, since you stated you are "new" be careful.
Took me many years to smart'en up. Tough game,but lots interesting time spent in playing the game. Not much different then poker when you get down to it.
I've been trading for 40 years and am still in the game.
Doing it now to give it away to my children.
Better off buying coke cola rarher then penny crap.
If you are new to trading/investing which investing this is not then please get the hell out of here.
You are fodder for the pros who control this space.
Benn there done that and am only responding because I came across AXMM acidentally.
Some crap that cost newbies there fortunes no matter how small or large.
Please head this advice.
Flat hierachy is the way to go. More power to the people who are in the trenches.
This is a good move fro the board and CEO.
Stock pps up 15 % ,float a measly 5.6 mill. And increased volume.
EXPLAIN the bad news or be dismissed.
Yes, nice to see cchp diversification,especially for hotels
It's a biotech. GHEESH. R&D costs necessary before product. And if you are not aware most biotech companies can't get to PH 3 trials and when they do it is NDA with the FDA. Then they have to make and sell product. Tough game.
Thing is you have to be patient, accumulate on dips for a core long term position and keep your fingers crossed for the big payout. And you can trade around weakness for short term profits. That's what I do with my biotechs.
I have just sold out my recent trade on the fabulous run up from Jan to last week. Am buying back in on this decline. NVAX will have catalysts coming up this year that most likely will give us another nice run up from the 7 to 8 levels. Always keep cash in the till just incase more dips occur.
GLTY